Financial Year |
March 31 2023 |
Monetary Funds |
586,260,082.32 |
Held-for-trading Financial Assets |
325,043.80 |
Notes Receivable |
63,789,585.16 |
Accounts Receivable |
404,893,560.39 |
Advances to Suppliers |
7,300,659.18 |
Other Receivables |
8,462,562.83 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
177,975,591.54 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
88,080,023.91 |
Total Current Assets |
1,386,423,960.55 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
2,856,262.97 |
Investment Properties |
-- |
Fixed Assetes |
342,318,829.73 |
Under-construction Projects |
1,868,626.20 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
11,648,508.37 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
5,481,077.34 |
Deferred Income Tax Assets |
33,774,182.77 |
Other Non-Current Assets |
13,305,162.75 |
Sub-Total of Non-Current Assets |
444,218,580.34 |
Total Assets |
1,830,642,540.89 |
Short-Term Loans |
20,127,330.72 |
Trading Financial liabilities |
869,151.35 |
Notes Payable |
105,588,601.00 |
Accounts Payable |
313,553,981.46 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
35,599,974.05 |
Taxes Payable |
7,674,470.49 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
19,772,348.49 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
8,413,632.86 |
Other Current Liabilities |
22,330,423.79 |
Sub-Total of Current Liabilities |
546,103,984.68 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
20,642,215.17 |
Deferred Income Tax Liabilities |
81,991.00 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
28,763,023.93 |
Total Liabilities |
574,867,008.61 |
Paid-In Capital(Or Share Stock) |
356,626,019.00 |
Capital Surplus |
781,206,306.35 |
Surplus Reserve |
27,661,719.39 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
169,267,341.85 |
Minority Stockholder's Interest |
2,675,771.69 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,253,099,760.59 |
Owner's Equity(Stockholder's Equity) |
1,255,775,532.28 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,830,642,540.89 |